Bisphosphonates may potentiate effects of thalidomide-dexamethasone combination in advanced multiple myeloma.
Ural
A Ugur
AU
Avcu
Ferit
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000556:secondary; D013792:Thalidomide / Q000008:administration & dosage / Q000627:therapeutic use
D004164:Diphosphonates; D013792:Thalidomide; D003907:Dexamethasone